Rosetta Genomics Ltd. Proceeds from Stock Options Exercised
Rosetta Genomics Ltd. reported Proceeds from Stock Options Exercised of $4.13 million for the 0-month period ending 2012-08-28, per its 6-K filed 2012-09-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2013-09-09
- 2012-08-28: Proceeds from Stock Options Exercised 0 month $4.13M.
- 2012-06-30: Proceeds from Stock Options Exercised 6 month $1.56M.
| Period end | Proceeds from Stock Options Exercised 0 month | Proceeds from Stock Options Exercised 6 month |
|---|---|---|
| 2012-08-28 | $4.13M 6-K · filed 2012-09-28 | |
| 2012-06-30 | $1.56M 6-K · filed 2013-09-09 |